Progressive Kidney Failure by Angiotensinogen Inactivation in the Germline.

angiotensinogen exome mass spectrometry mutation renin-angiotensin system

Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
15 Jul 2024
Historique:
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: aheadofprint

Résumé

Autosomal recessive renal tubular dysgenesis is a rare, usually fatal inherited disorder of the REN (renin)-angiotensin system. Herein, we report an adolescent individual experiencing an unknown chronic kidney disease and aim to provide novel insights into disease mechanisms. Exome sequencing for a gene panel associated with renal disease was performed. The REN-angiotensin system was assessed by comprehensive biochemical analysis in blood. REN expression was determined in primary tubular cells by quantitative polymerase chain reaction and in situ hybridization on kidney biopsy samples. Allele frequencies of heterozygous and biallelic deleterious variants were determined by analysis of the Genomics England 100,000 Genomes Project. The patient was delivered prematurely after oligohydramnios was detected during pregnancy. Postnatally, he recovered from third-degree acute kidney injury but developed chronic kidney disease stage G3b over time. Exome sequencing revealed a previously reported pathogenic homozygous missense variant, p.(Arg375Gln), in the Renal tubular dysgenesis may present as chronic kidney disease with a variable phenotype, necessitating broad genetic analysis for diagnosis. Functional analysis of the renin-angiotensin system in a patient with

Sections du résumé

BACKGROUND UNASSIGNED
Autosomal recessive renal tubular dysgenesis is a rare, usually fatal inherited disorder of the REN (renin)-angiotensin system. Herein, we report an adolescent individual experiencing an unknown chronic kidney disease and aim to provide novel insights into disease mechanisms.
METHODS UNASSIGNED
Exome sequencing for a gene panel associated with renal disease was performed. The REN-angiotensin system was assessed by comprehensive biochemical analysis in blood. REN expression was determined in primary tubular cells by quantitative polymerase chain reaction and in situ hybridization on kidney biopsy samples. Allele frequencies of heterozygous and biallelic deleterious variants were determined by analysis of the Genomics England 100,000 Genomes Project.
RESULTS UNASSIGNED
The patient was delivered prematurely after oligohydramnios was detected during pregnancy. Postnatally, he recovered from third-degree acute kidney injury but developed chronic kidney disease stage G3b over time. Exome sequencing revealed a previously reported pathogenic homozygous missense variant, p.(Arg375Gln), in the
CONCLUSIONS UNASSIGNED
Renal tubular dysgenesis may present as chronic kidney disease with a variable phenotype, necessitating broad genetic analysis for diagnosis. Functional analysis of the renin-angiotensin system in a patient with

Identifiants

pubmed: 39005223
doi: 10.1161/HYPERTENSIONAHA.124.22806
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Florian J Wopperer (FJ)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Eric Olinger (E)

Center for Human Genetics, Cliniques universitaires Saint-Luc, Brussels, Belgium (E.O.).
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom (E.O., J.A.S.).

Antje Wiesener (A)

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (A.W., A.R., F.P.).

Katharina A E Broeker (KAE)

Institute of Physiology, University of Regensburg, Germany. (K.A.E.B.).

Karl X Knaup (KX)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Jan T Schaefer (JT)

Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (J.T.S., M.G.).

Matthias Galiano (M)

Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (J.T.S., M.G.).

Karen Schneider (K)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Mario Schiffer (M)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Maike Büttner-Herold (M)

Department of Nephropathology, Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (M.B.-H.).

André Reis (A)

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (A.W., A.R., F.P.).

Roland Schmieder (R)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Francesca Pasutto (F)

Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (A.W., A.R., F.P.).

Karl F Hilgers (KF)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Marko Poglitsch (M)

Attoquant Diagnostics, Vienna, Austria (M.P.).

Christine Ziegler (C)

Department of Biophysics, University of Regensburg, Germany. (C.Z.).

Robin Shoemaker (R)

Department of Pediatrics, University of Kentucky, Lexington (R. Shoemaker).

John A Sayer (JA)

Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom (E.O., J.A.S.).

Michael S Wiesener (MS)

Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany. (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.).

Classifications MeSH